Display options
Share it on

Korean J Pathol. 2013 Oct;47(5):411-7. doi: 10.4132/KoreanJPathol.2013.47.5.411. Epub 2013 Oct 25.

Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases.

Korean journal of pathology

Hyunchul Kim, Ja-June Jang, Dong-Sik Kim, Beom Woo Yeom, Nam Hee Won

Affiliations

  1. Department of Pathology, Gachon University Gil Medical Center, Incheon, Korea.

PMID: 24255628 PMCID: PMC3830987 DOI: 10.4132/KoreanJPathol.2013.47.5.411

Abstract

BACKGROUND: Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group.

METHODS: We used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports.

RESULTS: Seven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for β-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA.

CONCLUSIONS: Although the new classification is now generally accepted, validation through follow-up studies is necessary.

Keywords: Adenoma, liver cell; Beta catenin; Hepatocyte nuclear factor 1-alpha; Serum amyloid A protein; Subtype

References

  1. Oncogene. 2002 Nov 28;21(54):8293-301 - PubMed
  2. N Engl J Med. 1976 Feb 26;294(9):470-2 - PubMed
  3. Oncogene. 1999 Nov 11;18(47):6583-8 - PubMed
  4. Nat Genet. 2002 Oct;32(2):312-5 - PubMed
  5. J Pathol. 2009 May;218(1):86-94 - PubMed
  6. Fertil Steril. 1997 Nov;68(5):865-70 - PubMed
  7. Histopathology. 2013 Feb;62(3):431-45 - PubMed
  8. Hepatology. 2009 Aug;50(2):481-9 - PubMed
  9. Gastroenterology. 2009 Nov;137(5):1698-705 - PubMed
  10. Gastroenterology. 2003 Nov;125(5):1470-5 - PubMed
  11. J Biol Chem. 2007 May 11;282(19):14437-46 - PubMed
  12. Hepatology. 2006 Mar;43(3):515-24 - PubMed
  13. Gynecol Obstet Invest. 2010;70(3):154-9 - PubMed
  14. J Hepatol. 2007 Mar;46(3):521-7 - PubMed
  15. Am J Surg Pathol. 2012 Nov;36(11):1691-9 - PubMed
  16. Hepatol Res. 2011 Oct;41(10):982-8 - PubMed
  17. Oncogene. 2007 Feb 1;26(5):774-80 - PubMed
  18. J Hepatol. 2011 Jul;55(1):120-5 - PubMed
  19. Korean J Intern Med. 2009 Jun;24(2):147-52 - PubMed
  20. Hepatology. 2007 Sep;46(3):740-8 - PubMed
  21. Hepatology. 2002 Oct;36(4 Pt 1):927-35 - PubMed
  22. Gastroenterology. 2005 May;128(5):1211-8 - PubMed
  23. Dig Surg. 2010;27(1):39-45 - PubMed
  24. JAMA. 1979 Aug 17;242(7):644-8 - PubMed
  25. N Engl J Med. 1978 Aug 3;299(5):239-41 - PubMed
  26. World J Gastroenterol. 2007 May 21;13(19):2649-54 - PubMed
  27. Gastroenterology. 2004 May;126(5):1323-9 - PubMed

Publication Types